This document proposes applying systems biology approaches to better understand multifactorial human diseases and co-morbidities. It involves analyzing the interactions between intrinsic genetic and extrinsic environmental factors. The study would investigate cross-interactions in regulatory pathways and metabolism of affected organs in patients with diseases like atherosclerosis and how they relate to an individual's reactivity. It would analyze platelets as sensors of the cardiovascular system and indicators of reactivity. The goals are to establish the role of reactivity in disease development, identify key regulatory factors in co-morbidities, and develop personalized treatment strategies.
The Complete Guide to Know about Cell Therapy from The Point of Standardizati...Bennie George
Cell therapy refers to the transplantation or input of normal or bioengineered human cells into a patient's body and newly-imported cells can replace damaged cells or involve a stronger immune killing function, so as to achieve the purpose of treating diseases. Cell therapy has shown higher application value in the treatment of cancer, hematological diseases, cardiovascular diseases, diabetes, Alzheimer's disease etc.
https://www.creative-bioarray.com/oncology.htm
The Complete Guide to Know about Cell Therapy from The Point of Standardizati...Bennie George
Cell therapy refers to the transplantation or input of normal or bioengineered human cells into a patient's body and newly-imported cells can replace damaged cells or involve a stronger immune killing function, so as to achieve the purpose of treating diseases. Cell therapy has shown higher application value in the treatment of cancer, hematological diseases, cardiovascular diseases, diabetes, Alzheimer's disease etc.
https://www.creative-bioarray.com/oncology.htm
Know about Cell Therapy from The Point of Standardization, Scale, and Industr...Bennie George
In general, cell therapy includes tumor cell immunotherapy and stem cell therapy. There are two cell sources for cell therapy, one from the patient itself and the other from the allogeneic tissue.
https://www.creative-bioarray.com/products/cytokines-growth-factors-17.htm
Exosomes have specialized functions and play a key role in different physiological processes and pathological conditions. Consequently, exosomes have attracted increasing attention in their clinical applications for prognosis,
https://www.creative-biolabs.com/exosome/applications.htm
Unlocking the Phytotherapeutic Synergism between Beta-lapachone and Soybean-...Saheed Oluwasina Oseni
The present in vitro study demonstrates that combination treatments with β-lap and genistein are more potent in killing both PC3 and LNCaP cancer cells than treatment with either genistein or β-lap alone, and therefore, could offer an effective chemotherapy against androgen dependent and independent prostate cancer. This result provides a rationale for in vivo studies and other therapeutic synergism.
Know about Cell Therapy from The Point of Standardization, Scale, and Industr...Bennie George
In general, cell therapy includes tumor cell immunotherapy and stem cell therapy. There are two cell sources for cell therapy, one from the patient itself and the other from the allogeneic tissue.
https://www.creative-bioarray.com/products/cytokines-growth-factors-17.htm
Exosomes have specialized functions and play a key role in different physiological processes and pathological conditions. Consequently, exosomes have attracted increasing attention in their clinical applications for prognosis,
https://www.creative-biolabs.com/exosome/applications.htm
Unlocking the Phytotherapeutic Synergism between Beta-lapachone and Soybean-...Saheed Oluwasina Oseni
The present in vitro study demonstrates that combination treatments with β-lap and genistein are more potent in killing both PC3 and LNCaP cancer cells than treatment with either genistein or β-lap alone, and therefore, could offer an effective chemotherapy against androgen dependent and independent prostate cancer. This result provides a rationale for in vivo studies and other therapeutic synergism.
TOXICOLOGY STUDY IS VERY ESSENTIAL FOR DRUG DISCOVERY. INTERNATIONAL COUNCIL FOR HARMONIZATION (ICH) HAS IMPLEMENTED SOME BASIC RULES AND REGULATION REGARDING THE TOXICITY STUDY ON ANIMAL DURING PRE-CLINICAL TRIAL, WHICH IS A PART OF DRUG DISCOVERY PROCESS. HERE SOME OF THE BASIC TEST ARE DISCUSSED ALONG WITH SOME BASIC CONCEPTS OF GENETICS. HOPE THIS WILL HELP THE STUDENTS TO UNDERSTAND THE TOPIC.
Molecular Mechanisms of Neurodegeneration: Neurodegenerative Disorders Webin...QIAGEN
Common molecular mechanisms and pathways leading to neurodegeneration, such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease or Multiple Sclerosis, are presented in this slideshow. Learn more about research and therapeutic strategies as well as how these discoveries and tools can be used to facilitate your neurodegeneration research.
The presentation is about the general concepts of Pathology from Robbin and Cotran, featuring the organization of the cell, injury & adaptation, and inflammation & repair
1. HEALTH.2012.2.1.2-2: SYSTEMS MEDICINE:
APPLYING SYSTEMS BIOLOGY APPROACHES FOR
UNDERSTANDING MULTIFACTORIAL HUMAN
DISEASES AND THEIR CO-MORBIDITIES
Partners:
- Donetsk national medical university
Departments of Histology, Cytology and Embryology, Propaedeutics of
Internal Medicine, Department of Dermatology, Medical Biophysics,
Medical Equipment and Clinical Informatics
-Laboratory of fundamental research (Institute of Urgent and
Recovery Surgery)
2. MULTIFACTORIAL HUMAN DISEASES AND
THEIR CO-MORBIDITIES
Genotype Embryonic Life Style
development
Diet, nutrients Environmental factors
4. Immunopatholgy Endocrinological
Endocrinological Autonomic system
Autonomic system
Immunopatholgy
disturbance
disturbance dysregulacation
dysregulacation
Metabolical disturbance
Metabolical disturbance
Digestive system
Digestive system
pathology Coronary
Coronary
pathology
Atherosclerosis
Atherosclerosis diseases
diseases
Obesity
Obesity Diabetes
Diabetes
Co-morbidities of multifactorial diseases
5. Proposition
Investigation of Cross-interactions in regulatory axis and
metabolic ways of affected organs and their dependence on
individual reactivity of organism
Gene polymorphism
Cells response and resistance to different stimuli
6. PROPOSED DESIGN OF INVESTIGATION
PATIENTS WITH:
ATHEROSCLEROSIS
ANGINA. INFARCTION OF MYOCARDIUM
ISCHEMIC STROKE
PEPTIC ULCERS OF STOMACH AND DUODENUM
METHODS: Clinical Morphological
Instrumental Immunocytochemical
Laboratory Moleculo-genetic
Biochemical Biostatistics,
Immunoenzymological Neurocybernetics
7. PROPOSED DESIGN OF INVESTIGATION
Regulatory axis Network analysis Interlinks / co-morbities
in affected organ, system
Organ specific regulators
Regenerative potential State of innate and
Metabolic peculiarities adaptive immunity
8. PROPOSED MODEL FOR ANALYSIS
PLATELETS PLATELETS
Participate in: Are targets for:
- atherothrombosis - Hormones
- inflammation - Neurotransmitters
- vessels remodeling - cytokines
- reparation - chemokines
PLATELETS AS SENSORS OF CARDIOVACULAR SYSTEM AND MIRROW OF REACTIVITY
In vitro analysis of:
Aggregation Intracellular signaling systems
Sensitivity to systemic and organospecific Granules and hyaloplasm content
regulators Enzymes activity
9. EXPEXTED RESULTS
1. Establish the role and key determinants of reactivity of organism in
organospecific pattern of multifactorial diseases.
2. Detect the key regulatory factors in development, progression and risk
of co-morbid pathology associated with AS.
3. Develop the system of prognostic criteria of organospecific
manifestation of atherosclerosis.
DEVELOPMENT OF INDIVIDUALIZED
STRATEGY OF THERAPY
Editor's Notes
Multifactorial human diseases are related with many factors including genotype, ontogenesis conditions (CONSTITUTIVE) , environmental factors and others
The same combination of extrinsic factors can led to different clinical manifestation and co-morbidities complex